BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38290775)

  • 61.
    Chopra S; Mathur Y; Roesch F; Moon ES; Rana N; Irrinki S; Walia R; Duseja A; Singh H; Kumar R; Shukla J; Mittal BR
    Acad Radiol; 2024 Jun; 31(6):2521-2535. PubMed ID: 38233261
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 63.
    Kömek H; Can C; Güzel Y; Oruç Z; Gündoğan C; Yildirim ÖA; Kaplan İ; Erdur E; Yıldırım MS; Çakabay B
    Ann Nucl Med; 2021 Jun; 35(6):744-752. PubMed ID: 33934311
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study.
    Chen SH; Lin BH; Chen SM; Qiu QR; Ruan ZT; Chen ZJ; Wei Y; Zheng QS; Xue XY; Miao WB; Xu N
    Int Braz J Urol; 2023; 49(6):716-731. PubMed ID: 37624658
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of
    Sayiner ZA; Elboğa U; Sahin E; Ozturk S; Cayirli YB; Celen YZ; Akarsu E; Dogan I; Kilbas B; Eryilmaz K; Cakici D
    Hell J Nucl Med; 2023; 26(1):41-46. PubMed ID: 37115220
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Dendl K; Koerber SA; Finck R; Mokoala KMG; Staudinger F; Schillings L; Heger U; Röhrich M; Kratochwil C; Sathekge M; Jäger D; Debus J; Haberkorn U; Giesel FL
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4089-4100. PubMed ID: 34050777
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospective Comparison of
    Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
    Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
    J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial.
    Bentestuen M; Ladekarl M; Knudsen A; Zacho HD
    BMC Cancer; 2024 Jun; 24(1):699. PubMed ID: 38849741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
    Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
    Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Wang H; Zhu W; Ren S; Kong Y; Huang Q; Zhao J; Guan Y; Jia H; Chen J; Lu L; Xie F; Qin L
    Front Oncol; 2021; 11():693640. PubMed ID: 34249748
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
    Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Head-To-Head Comparison of
    Gege Z; Xueju W; Bin J
    AJR Am J Roentgenol; 2023 Apr; 220(4):490-498. PubMed ID: 36321984
    [No Abstract]   [Full Text] [Related]  

  • 75. Feasibility of [
    Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of
    Güzel Y; Kaplan İ
    Hell J Nucl Med; 2023; 26(1):26-34. PubMed ID: 37031420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical utility of
    Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of Baseline
    Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
    J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    Qin C; Shao F; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Lan X
    J Nucl Med; 2022 Jan; 63(1):81-88. PubMed ID: 33863819
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome.
    Wang P; Li C; Hou G; Li Z; Jing H; Zhang W; Li F
    Clin Nucl Med; 2023 Sep; 48(9):781-784. PubMed ID: 37543757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.